• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Bio-Works Technologies

3.25 SEK

-8.96 %

Less than 1K followers

BIOWKS

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-8.96 %
-23.35 %
+2.85 %
+24.05 %
+38.89 %
+96.97 %
-64.79 %
-71.05 %
-62.18 %

Bio-Works Technologies operates in biotechnology. The company develops products that separate and purify molecules in the production of pharmaceuticals. The technology is based on chromatography, which is intended to handle the drug substance. Customers are found in the European market where the products are sold via distribution partners and to companies in the pharmaceutical industry, as well as research institutes and universities. The company was founded in 2006 and has its headquarters in Uppsala.

Read more
Market cap
325.04M SEK
Turnover
294.68K SEK
Revenue
62.5M
EBIT %
-28.03 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21/8
2026

Interim report Q2'26

6/11
2026

Interim report Q3'26

19/2
2027

Annual report '26

Regulatory press release6/4/2026, 8:20 AM

Bio-Works Technologies AB: Resolutions passed at Bio-Works Technologies' annual general meeting 2026

Bio-Works Technologies
Regulatory press release6/4/2026, 8:20 AM

Bio-Works Technologies AB: Kommuniké från Bio-Works Technologies årsstämma 2026

Bio-Works Technologies
Regulatory press release5/13/2026, 6:00 AM

Bio-Works Technologies AB: Bio-Works reports first quarter 2026

Bio-Works Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/13/2026, 6:00 AM

Bio-Works Technologies AB: Bio-Works rapporterar första kvartalet 2026

Bio-Works Technologies
Regulatory press release4/29/2026, 1:17 PM

Bio-Works Technologies AB: Bio-Works receives order for WorkBeads 40S from contract manufacturer in Europe

Bio-Works Technologies
Regulatory press release4/29/2026, 1:17 PM

Bio-Works Technologies AB: Bio-Works erhåller order på WorkBeads 40S till kontraktstillverkare i Europa

Bio-Works Technologies
Regulatory press release4/28/2026, 6:00 AM

Bio-Works Technologies AB: Kallelse till årsstämma i Bio-Works Technologies

Bio-Works Technologies
Regulatory press release4/17/2026, 12:00 PM

Bio-Works Technologies AB meddelar utfall från inlösen av teckningsoptioner av serie TO 2. Nyttjandeperiod 6 av 11

Bio-Works Technologies
Regulatory press release4/17/2026, 12:00 PM

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 6 of 11

Bio-Works Technologies
Regulatory press release4/17/2026, 10:00 AM

Bio-Works Technologies AB: Bio-Works publicerar årsredovisningen 2025

Bio-Works Technologies
Regulatory press release4/10/2026, 6:00 AM

Bio-Works Technologies AB: Förslag till nya styrelseledamöter i Bio-Works

Bio-Works Technologies
Regulatory press release4/10/2026, 6:00 AM

Bio-Works Technologies AB: Proposed New Board Members in Bio-Works

Bio-Works Technologies
Regulatory press release4/1/2026, 6:00 AM

Idag inleds den sjätte nyttjandeperioden för Bio-Works Technologies AB:s teckningsoptioner av serie TO 2

Bio-Works Technologies
Regulatory press release4/1/2026, 6:00 AM

Today is the first day of the sixth exercise period for Bio-Works Technologies AB's warrants of series TO 2

Bio-Works Technologies
Regulatory press release4/1/2026, 6:00 AM

Bio-Works Technologies AB - Business Update första kvartalet 2026

Bio-Works Technologies
Regulatory press release4/1/2026, 6:00 AM

Bio-Works Technologies AB - Business Update first quarter 2026

Bio-Works Technologies
Press release3/13/2026, 12:29 PM

Redeye: Bio-Works (Intervju): Verksamhetsuppdatering

Bio-Works Technologies
Regulatory press release3/6/2026, 1:00 PM

Bio-Works Technologies AB publishes Business Update ahead of next value creation phase

Bio-Works Technologies
Regulatory press release3/6/2026, 1:00 PM

Bio-Works Technologies AB publicerar verksamhetsuppdatering inför nästa värdeskapande fas

Bio-Works Technologies
Regulatory press release2/20/2026, 7:00 AM

Bio-Works Technologies AB: Bio-Works publishes Year-end report Q4 2025

Bio-Works Technologies